159 related articles for article (PubMed ID: 26616174)
41. Metformin synergistically enhances antitumor activity of histone deacetylase inhibitor trichostatin a against osteosarcoma cell line.
Duo J; Ma Y; Wang G; Han X; Zhang C
DNA Cell Biol; 2013 Apr; 32(4):156-64. PubMed ID: 23451817
[TBL] [Abstract][Full Text] [Related]
42. Unraveling the Light-Specific Metabolic and Regulatory Signatures of Rice through Combined in Silico Modeling and Multiomics Analysis.
Lakshmanan M; Lim SH; Mohanty B; Kim JK; Ha SH; Lee DY
Plant Physiol; 2015 Dec; 169(4):3002-20. PubMed ID: 26453433
[TBL] [Abstract][Full Text] [Related]
43. Effects of metformin on proliferation and apoptosis of human megakaryoblastic Dami and MEG-01 cells.
Liang X; Kong P; Wang J; Xu Y; Gao C; Guo G
J Pharmacol Sci; 2017 Sep; 135(1):14-21. PubMed ID: 28927780
[TBL] [Abstract][Full Text] [Related]
44. Metformin-induced mitochondrial function and ABCD2 up-regulation in X-linked adrenoleukodystrophy involves AMP-activated protein kinase.
Singh J; Olle B; Suhail H; Felicella MM; Giri S
J Neurochem; 2016 Jul; 138(1):86-100. PubMed ID: 26849413
[TBL] [Abstract][Full Text] [Related]
45. Combining biochemical with (1)H NMR-based metabolomics approach unravels the antidiabetic activity of genipin and its possible mechanism.
Shen XL; Liu H; Xiang H; Qin XM; Du GH; Tian JS
J Pharm Biomed Anal; 2016 Sep; 129():80-89. PubMed ID: 27411170
[TBL] [Abstract][Full Text] [Related]
46. Transcriptomic analysis of pancreatic cancer cells in response to metformin and aspirin: an implication of synergy.
Yue W; Wang T; Zachariah E; Lin Y; Yang CS; Xu Q; DiPaola RS; Tan XL
Sci Rep; 2015 Aug; 5():13390. PubMed ID: 26294325
[TBL] [Abstract][Full Text] [Related]
47. Metformin inhibits glioma cell U251 invasion by downregulation of fibulin-3.
Gao LB; Tian S; Gao HH; Xu YY
Neuroreport; 2013 Jul; 24(10):504-8. PubMed ID: 23660683
[TBL] [Abstract][Full Text] [Related]
48. Metabolomics analysis of metabolic effects of nicotinamide phosphoribosyltransferase (NAMPT) inhibition on human cancer cells.
Tolstikov V; Nikolayev A; Dong S; Zhao G; Kuo MS
PLoS One; 2014; 9(12):e114019. PubMed ID: 25486521
[TBL] [Abstract][Full Text] [Related]
49. Metabolic profile of Diane-35 versus Diane-35 plus metformin in Chinese PCOS women under standardized life-style changes.
Wu H; Ruan X; Jin J; Mueck AO
Gynecol Endocrinol; 2015 Jul; 31(7):548-51. PubMed ID: 26004979
[TBL] [Abstract][Full Text] [Related]
50. Metformin treatment response is dependent on glucose growth conditions and metabolic phenotype in colorectal cancer cells.
Alhourani AH; Tidwell TR; Bokil AA; Røsland GV; Tronstad KJ; Søreide K; Hagland HR
Sci Rep; 2021 May; 11(1):10487. PubMed ID: 34006970
[TBL] [Abstract][Full Text] [Related]
51. Metformin induces cytotoxicity by down-regulating thymidine phosphorylase and excision repair cross-complementation 1 expression in non-small cell lung cancer cells.
Ko JC; Huang YC; Chen HJ; Tseng SC; Chiu HC; Wo TY; Huang YJ; Weng SH; Chiou RY; Lin YW
Basic Clin Pharmacol Toxicol; 2013 Jul; 113(1):56-65. PubMed ID: 23362830
[TBL] [Abstract][Full Text] [Related]
52. Butyrate and Metformin Affect Energy Metabolism Independently of the Metabolic Phenotype in the Tumor Therapy Model.
Meyer FB; Marx C; Spangel SB; Thierbach R
Biomolecules; 2021 Dec; 11(12):. PubMed ID: 34944475
[TBL] [Abstract][Full Text] [Related]
53. Effects of metformin on glucose metabolism of perfused rat livers.
Silva FM; da Silva MH; Bracht A; Eller GJ; Constantin RP; Yamamoto NS
Mol Cell Biochem; 2010 Jul; 340(1-2):283-9. PubMed ID: 20217188
[TBL] [Abstract][Full Text] [Related]
54. Metformin and cancer: Between the bioenergetic disturbances and the antifolate activity.
Jara JA; López-Muñoz R
Pharmacol Res; 2015 Nov; 101():102-8. PubMed ID: 26277279
[TBL] [Abstract][Full Text] [Related]
55. Biochemical effects of venlafaxine on astrocytes as revealed by
Sun L; Fang L; Lian B; Xia JJ; Zhou CJ; Wang L; Mao Q; Wang XF; Gong X; Liang ZH; Bai SJ; Liao L; Wu Y; Xie P
Mol Biosyst; 2017 Jan; 13(2):338-349. PubMed ID: 28045162
[TBL] [Abstract][Full Text] [Related]
56. Metformin: a metabolic modulator.
Pietrocola F; Kroemer G
Oncotarget; 2017 Feb; 8(6):9017-9020. PubMed ID: 28122334
[TBL] [Abstract][Full Text] [Related]
57. Metformin strongly affects transcriptome of peripheral blood cells in healthy individuals.
Ustinova M; Silamikelis I; Kalnina I; Ansone L; Rovite V; Elbere I; Radovica-Spalvina I; Fridmanis D; Aladyeva J; Konrade I; Pirags V; Klovins J
PLoS One; 2019; 14(11):e0224835. PubMed ID: 31703101
[TBL] [Abstract][Full Text] [Related]
58. Identification of cisplatin-regulated metabolic pathways in pluripotent stem cells.
von Stechow L; Ruiz-Aracama A; van de Water B; Peijnenburg A; Danen E; Lommen A
PLoS One; 2013; 8(10):e76476. PubMed ID: 24146875
[TBL] [Abstract][Full Text] [Related]
59. Metformin induces the AP-1 transcription factor network in normal dermal fibroblasts.
Gillespie ZE; Wang C; Vadan F; Yu TY; Ausió J; Kusalik A; Eskiw CH
Sci Rep; 2019 Mar; 9(1):5369. PubMed ID: 30926854
[TBL] [Abstract][Full Text] [Related]
60. Metformin-induced metabolic reprogramming of chemoresistant ALDHbright breast cancer cells.
Cioce M; Valerio M; Casadei L; Pulito C; Sacconi A; Mori F; Biagioni F; Manetti C; Muti P; Strano S; Blandino G
Oncotarget; 2014 Jun; 5(12):4129-43. PubMed ID: 24980829
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
